Enlivex Therapeutics Ltd. buy Liberte
Start price
03.10.20
/
50%
€11.30
Target price
04.11.21
-
Performance (%)
-43.36%
End price
20.07.21
€6.40
Summary
This prediction ended on 20.07.21 with a price of €6.40. Massive losses of -43.36% were the result for the BUY prediction by Liberte. Liberte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Enlivex Therapeutics Ltd. | -1.600% | -1.600% | -44.595% | -81.504% |
iShares Core DAX® | 0.383% | -1.593% | 16.084% | 14.286% |
iShares Nasdaq 100 | 1.543% | 7.530% | 38.446% | 53.091% |
iShares Nikkei 225® | 2.596% | 4.525% | 14.539% | 9.353% |
iShares S&P 500 | 0.573% | 4.229% | 30.110% | 45.397% |
According to Liberte what are the pros and cons of Enlivex Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Liberte for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Buy Bio Blast Pharma Ltd